VINBLASTINE GLS 10
Description
Vinblastine was isolated in 1958.An example of a natural herbal remedy that has since been developed into a conventional medicine, vinblastine was originally obtained from the Madagascar periwinkle. It is on the World Health Organization's List of Essential Medicines. Vinblastine's utility as a chemotherapeutic agent was first suggested by its effect on the body when an extract of the plant was injected in rabbits to study the plant's supposed anti-diabetic effect. (A tea made from the plant was a folk-remedy for diabetes.)
Indications:
In the palliative treatment of the following:
Frequently Responsive Malignancies
- Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)
- Lymphocytic lymphoma (nodular and diffuse, poorly and well differentiated)
- Histiocytic lymphoma
- Mycosis fungoides (advanced stages)
- Advanced carcinoma of the testis
- Kaposi's sarcoma
- Letterer-Siwe disease (histiocytosis X)
Less Frequently Responsive Malignancies
- Choriocarcinoma resistant to other chemotherapeutic agents
- Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy
| Generic Name> | Strength | Standard | Type | Packing | Pack size |
| Vinblastine | 10mg | USP | Liquid Injection | Vial | 10ml Vial |